Assisted reproductive technologies have been used extensively for humans and domestic animals to advance our knowledge of reproductive processes, promote reproductive efficiency, and preserve valuable genetics.
Recent advances include the continued development of sex-sorting technologies and the development of advanced procedures, such as oocyte transfer and intracytoplasmic sperm injection. Equine assisted reproduction is being used to produce offspring from mares and stallions that otherwise would be considered infertile and to preserve valuable bloodlines. Substantial developments have been made in oocyte transfer, embryo cryopreservation, intracytoplasmic sperm injection, and harvesting of gametes from valuable mares or stallions after death.
In addition to being well known for research associated with ART applications in humans, cattle, and horses, and approaches toward controlling or inhibiting reproduction in wildlife and pet animals, ARBL faculty have research programs that are directly connected to state, national, and international concerns regarding environmental toxicology and the impacts of pollutants on mammalian development and reproduction.
Fifteen former ARBL graduate and postdoctoral students direct human in vitro fertilization clinics, and many others hold academic appointments or are leaders in equine, bovine, porcine, and ovine biotechnology industries.
Spinoff companies (e.g., XY Inc., Gonex) evolved from ARBL research in ART and related technologies.
A dozen ARBL patents have been filed, and licensing agreements continue to be developed with industry and biotechnology companies.
Learn more about the work our faculty are doing by visiting our faculty profile pages.